

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.09391119 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.94662667 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.94662667 |
| 4 | cellular extravasation (GO:0045123) | 4.71738156 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.57057981 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.56020769 |
| 7 | response to muramyl dipeptide (GO:0032495) | 4.17327627 |
| 8 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.01759964 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 3.98892744 |
| 10 | regulation of chemokine biosynthetic process (GO:0045073) | 3.86345178 |
| 11 | germinal center formation (GO:0002467) | 3.78200009 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.74056840 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68209345 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.62982781 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.62982781 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.62982781 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.62982781 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.62982781 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.62982781 |
| 20 | defense response to protozoan (GO:0042832) | 3.59341644 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.56390133 |
| 22 | leukocyte aggregation (GO:0070486) | 3.51112219 |
| 23 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.46577334 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.40458556 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40220998 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38050225 |
| 27 | response to protozoan (GO:0001562) | 3.34400623 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27350231 |
| 29 | regulation of leukocyte degranulation (GO:0043300) | 3.21308888 |
| 30 | negative regulation of phagocytosis (GO:0050765) | 3.19726984 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17233977 |
| 32 | granulocyte activation (GO:0036230) | 3.13197946 |
| 33 | microglial cell activation (GO:0001774) | 3.12663696 |
| 34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09855685 |
| 35 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.07813383 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06193414 |
| 37 | macrophage activation (GO:0042116) | 3.05363449 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04205110 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02196228 |
| 40 | detection of bacterium (GO:0016045) | 3.00499825 |
| 41 | detection of other organism (GO:0098543) | 2.98925815 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 2.98348741 |
| 43 | neutrophil activation (GO:0042119) | 2.97136965 |
| 44 | mannose metabolic process (GO:0006013) | 2.94686487 |
| 45 | negative regulation of innate immune response (GO:0045824) | 2.94575132 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94262252 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 2.94262252 |
| 48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93715225 |
| 49 | cellular response to type I interferon (GO:0071357) | 2.91811326 |
| 50 | type I interferon signaling pathway (GO:0060337) | 2.91811326 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91445928 |
| 52 | response to type I interferon (GO:0034340) | 2.91168227 |
| 53 | neutrophil mediated immunity (GO:0002446) | 2.91061136 |
| 54 | respiratory burst (GO:0045730) | 2.90960761 |
| 55 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90539932 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90367893 |
| 57 | positive regulation of heat generation (GO:0031652) | 2.89155411 |
| 58 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.88493780 |
| 59 | T-helper cell differentiation (GO:0042093) | 2.88493780 |
| 60 | activation of MAPKKK activity (GO:0000185) | 2.86162869 |
| 61 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.83197789 |
| 62 | induction of positive chemotaxis (GO:0050930) | 2.83079430 |
| 63 | negative regulation of growth of symbiont in host (GO:0044130) | 2.82784936 |
| 64 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.82784936 |
| 65 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.82784936 |
| 66 | regulation of growth of symbiont in host (GO:0044126) | 2.82784936 |
| 67 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82549827 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82391399 |
| 69 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.81636223 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 2.79819625 |
| 71 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72054963 |
| 72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.71873540 |
| 73 | positive regulation of mast cell activation (GO:0033005) | 2.71665906 |
| 74 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.70087704 |
| 75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70034267 |
| 76 | eosinophil chemotaxis (GO:0048245) | 2.67703637 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 2.67400980 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.67359481 |
| 79 | protein localization to endosome (GO:0036010) | 2.64684140 |
| 80 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.63269287 |
| 81 | positive regulation of leukocyte degranulation (GO:0043302) | 2.63071911 |
| 82 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.62624682 |
| 83 | regulation of regulated secretory pathway (GO:1903305) | 2.62424736 |
| 84 | B cell mediated immunity (GO:0019724) | 2.58931653 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58399493 |
| 86 | regulation of interferon-alpha production (GO:0032647) | 2.57537835 |
| 87 | positive thymic T cell selection (GO:0045059) | 2.57201663 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57147934 |
| 89 | glycosphingolipid catabolic process (GO:0046479) | 2.55648089 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55512391 |
| 91 | regulation of tumor necrosis factor production (GO:0032680) | 2.55260186 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.51285154 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51033285 |
| 94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50656045 |
| 95 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50656045 |
| 96 | regulation of mast cell activation (GO:0033003) | 2.50645175 |
| 97 | regulation of fever generation (GO:0031620) | 2.50056648 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.46896031 |
| 99 | T cell migration (GO:0072678) | 2.46109503 |
| 100 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45857042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.65370453 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20880012 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.87233055 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.74888784 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66374422 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.57816069 |
| 7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55129585 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53792536 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.51079881 |
| 10 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.45155487 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34480949 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34097590 |
| 13 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31726333 |
| 14 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.25877475 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22340595 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.20382178 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.18320258 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17538144 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16227943 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15293040 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10302268 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09616658 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07142934 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03499848 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98227245 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98055546 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.90725152 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89047110 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88334186 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87997413 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86808564 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83901596 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83644644 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81919697 |
| 35 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.78337636 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77971039 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77717395 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77231727 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73306797 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71431109 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70145898 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65721036 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59338388 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53426150 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.53357068 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49222626 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49049411 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48342106 |
| 49 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46228547 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42891540 |
| 51 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42785840 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41858065 |
| 53 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40069528 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39419336 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.38943242 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37594910 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37015051 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.34586330 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34246204 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33845226 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33785763 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33386399 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32354847 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29303533 |
| 65 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.29014793 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29011218 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28748452 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28554656 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26423027 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26331012 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25704463 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25637202 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25545369 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25493857 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24585295 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23230463 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22546725 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19869555 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16424553 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15157239 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15028091 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14758367 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13993286 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13579719 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13430967 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12935877 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12649489 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11101952 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09506392 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09111505 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07940436 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06510217 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06027533 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05390958 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04457070 |
| 96 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03788491 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02465649 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02077854 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99970900 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97497077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.05017298 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.86496103 |
| 3 | MP0003436_decreased_susceptibility_to | 3.78651562 |
| 4 | MP0004510_myositis | 2.87086148 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.83521916 |
| 6 | MP0009278_abnormal_bone_marrow | 2.76108323 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.66322000 |
| 8 | MP0002419_abnormal_innate_immunity | 2.63238098 |
| 9 | MP0006082_CNS_inflammation | 2.62779989 |
| 10 | MP0005025_abnormal_response_to | 2.58255165 |
| 11 | MP0003724_increased_susceptibility_to | 2.55693375 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.51400164 |
| 13 | MP0009785_altered_susceptibility_to | 2.50746979 |
| 14 | MP0005387_immune_system_phenotype | 2.49125660 |
| 15 | MP0001790_abnormal_immune_system | 2.49125660 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.34403436 |
| 17 | MP0000685_abnormal_immune_system | 2.33198376 |
| 18 | MP0001800_abnormal_humoral_immune | 2.32007966 |
| 19 | MP0005671_abnormal_response_to | 2.31961647 |
| 20 | MP0002723_abnormal_immune_serum | 2.25732573 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.19790503 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.18880695 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.16850366 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.11804922 |
| 25 | MP0001819_abnormal_immune_cell | 2.10350808 |
| 26 | MP0004947_skin_inflammation | 2.08242881 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.00596212 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.91455247 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.88886397 |
| 30 | MP0005451_abnormal_body_composition | 1.87429983 |
| 31 | MP0005310_abnormal_salivary_gland | 1.86485192 |
| 32 | MP0001873_stomach_inflammation | 1.85848590 |
| 33 | MP0002254_reproductive_system_inflammat | 1.79710273 |
| 34 | MP0002405_respiratory_system_inflammati | 1.77865652 |
| 35 | MP0009840_abnormal_foam_cell | 1.72523894 |
| 36 | MP0000858_altered_metastatic_potential | 1.68646111 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.67364463 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.65681405 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.64385823 |
| 40 | MP0000716_abnormal_immune_system | 1.62080281 |
| 41 | MP0002398_abnormal_bone_marrow | 1.60989249 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.58827268 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.58827268 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.57873589 |
| 45 | MP0001853_heart_inflammation | 1.55298123 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.54375909 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.49565341 |
| 48 | MP0009764_decreased_sensitivity_to | 1.39669380 |
| 49 | MP0008469_abnormal_protein_level | 1.38831713 |
| 50 | MP0003075_altered_response_to | 1.37381673 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.36535586 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.30274611 |
| 53 | MP0002722_abnormal_immune_system | 1.29716671 |
| 54 | MP0002429_abnormal_blood_cell | 1.28685431 |
| 55 | MP0003279_aneurysm | 1.27130083 |
| 56 | MP0000343_altered_response_to | 1.24529269 |
| 57 | MP0000490_abnormal_crypts_of | 1.24113514 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.23493975 |
| 59 | MP0008260_abnormal_autophagy | 1.22614539 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.22565820 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.19504835 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.18189174 |
| 63 | MP0004381_abnormal_hair_follicle | 1.12450697 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.09859873 |
| 65 | MP0000604_amyloidosis | 0.98884925 |
| 66 | MP0003866_abnormal_defecation | 0.98681335 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.95849877 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.93730518 |
| 69 | MP0002796_impaired_skin_barrier | 0.91568623 |
| 70 | MP0003448_altered_tumor_morphology | 0.90479106 |
| 71 | MP0001663_abnormal_digestive_system | 0.88699254 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.86998619 |
| 73 | MP0003828_pulmonary_edema | 0.83055929 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.82979049 |
| 75 | MP0005166_decreased_susceptibility_to | 0.81686230 |
| 76 | MP0005164_abnormal_response_to | 0.79226796 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.79038041 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.77549906 |
| 79 | MP0005501_abnormal_skin_physiology | 0.76269062 |
| 80 | MP0005390_skeleton_phenotype | 0.75529082 |
| 81 | MP0002933_joint_inflammation | 0.73620953 |
| 82 | MP0009763_increased_sensitivity_to | 0.73321165 |
| 83 | MP0003795_abnormal_bone_structure | 0.71495977 |
| 84 | MP0000249_abnormal_blood_vessel | 0.71475725 |
| 85 | MP0004883_abnormal_blood_vessel | 0.71075106 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.70955884 |
| 87 | MP0001851_eye_inflammation | 0.70110105 |
| 88 | MP0008004_abnormal_stomach_pH | 0.69894123 |
| 89 | MP0010307_abnormal_tumor_latency | 0.69636097 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.69156536 |
| 91 | MP0008874_decreased_physiological_sensi | 0.67434090 |
| 92 | MP0006054_spinal_hemorrhage | 0.66994280 |
| 93 | MP0000371_diluted_coat_color | 0.64548160 |
| 94 | MP0001849_ear_inflammation | 0.63884592 |
| 95 | MP0003091_abnormal_cell_migration | 0.63217497 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.62953581 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.62795487 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.59961519 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.59636214 |
| 100 | MP0001191_abnormal_skin_condition | 0.59326037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.70756784 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.70756784 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.70756784 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.35871147 |
| 5 | Dysostosis multiplex (HP:0000943) | 4.24188781 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.13091102 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.07620334 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.99836739 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.59387807 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.59189000 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.59189000 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.59189000 |
| 13 | Thin bony cortex (HP:0002753) | 3.33980549 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.32182618 |
| 15 | Obstructive lung disease (HP:0006536) | 3.32182618 |
| 16 | Stomatitis (HP:0010280) | 3.23379042 |
| 17 | Loss of speech (HP:0002371) | 3.18623463 |
| 18 | Meningitis (HP:0001287) | 3.14404748 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.11966457 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07004660 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03132388 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.03132388 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02151938 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02151938 |
| 25 | Myositis (HP:0100614) | 2.99027248 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.98388643 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.95445447 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.88795514 |
| 29 | Recurrent skin infections (HP:0001581) | 2.85113013 |
| 30 | Orchitis (HP:0100796) | 2.80690662 |
| 31 | Increased serum ferritin (HP:0003281) | 2.79378309 |
| 32 | Increased IgE level (HP:0003212) | 2.78552715 |
| 33 | Disinhibition (HP:0000734) | 2.78066884 |
| 34 | Vasculitis (HP:0002633) | 2.77753990 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.77065731 |
| 36 | Hepatosplenomegaly (HP:0001433) | 2.76580262 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.70300965 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69680629 |
| 39 | Cellulitis (HP:0100658) | 2.69558608 |
| 40 | Hemoptysis (HP:0002105) | 2.63598903 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.54350509 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54123006 |
| 43 | Chest pain (HP:0100749) | 2.50007353 |
| 44 | Optic neuritis (HP:0100653) | 2.49883439 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.49883439 |
| 46 | Petechiae (HP:0000967) | 2.47802731 |
| 47 | Apathy (HP:0000741) | 2.46505970 |
| 48 | Purpura (HP:0000979) | 2.45464074 |
| 49 | Gingivitis (HP:0000230) | 2.44671965 |
| 50 | Diminished motivation (HP:0000745) | 2.44037955 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.42324340 |
| 52 | Axonal loss (HP:0003447) | 2.42181108 |
| 53 | Colitis (HP:0002583) | 2.33629751 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.33534095 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.23227882 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.22101297 |
| 57 | Urticaria (HP:0001025) | 2.20397678 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.19078237 |
| 59 | Pustule (HP:0200039) | 2.16836472 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 2.15325146 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.14715856 |
| 62 | Restrictive lung disease (HP:0002091) | 2.14038617 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13615474 |
| 64 | Amyloidosis (HP:0011034) | 2.11242877 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.11130142 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.10566285 |
| 67 | Bone pain (HP:0002653) | 2.09664850 |
| 68 | Basal ganglia calcification (HP:0002135) | 2.09126745 |
| 69 | Recurrent viral infections (HP:0004429) | 2.08431650 |
| 70 | J-shaped sella turcica (HP:0002680) | 2.08369512 |
| 71 | Gangrene (HP:0100758) | 2.08046541 |
| 72 | Mutism (HP:0002300) | 2.06696030 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.04948795 |
| 74 | Pulmonary embolism (HP:0002204) | 2.04008402 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.03725553 |
| 76 | Granulocytopenia (HP:0001913) | 2.02753009 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.00768280 |
| 78 | Hematochezia (HP:0002573) | 1.98239757 |
| 79 | Epistaxis (HP:0000421) | 1.96909709 |
| 80 | Upper motor neuron abnormality (HP:0002127) | 1.95907058 |
| 81 | Abnormality of the pleura (HP:0002103) | 1.94404569 |
| 82 | Personality changes (HP:0000751) | 1.93933918 |
| 83 | Flat acetabular roof (HP:0003180) | 1.90743649 |
| 84 | Slow saccadic eye movements (HP:0000514) | 1.90593806 |
| 85 | Nuclear cataract (HP:0100018) | 1.90534137 |
| 86 | Osteomyelitis (HP:0002754) | 1.88173627 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 1.88111635 |
| 88 | Metaphyseal irregularity (HP:0003025) | 1.86974049 |
| 89 | Sepsis (HP:0100806) | 1.82978760 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 1.80742122 |
| 91 | Encephalitis (HP:0002383) | 1.80713043 |
| 92 | Episodic fever (HP:0001954) | 1.80088089 |
| 93 | Hemorrhage of the eye (HP:0011885) | 1.79716417 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 1.78588130 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 1.78225370 |
| 96 | Increased IgM level (HP:0003496) | 1.77928693 |
| 97 | Ragged-red muscle fibers (HP:0003200) | 1.77052045 |
| 98 | Pathologic fracture (HP:0002756) | 1.75323217 |
| 99 | Leukocytosis (HP:0001974) | 1.74908744 |
| 100 | Flat occiput (HP:0005469) | 1.73466192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.91893939 |
| 2 | TRIB3 | 3.55415933 |
| 3 | MAP4K1 | 3.38441363 |
| 4 | IRAK3 | 2.52231576 |
| 5 | IRAK4 | 2.47694762 |
| 6 | TBK1 | 2.35668177 |
| 7 | PRPF4B | 2.26522166 |
| 8 | MAP3K11 | 2.21545887 |
| 9 | RIPK4 | 2.20521121 |
| 10 | TAOK1 | 2.18791302 |
| 11 | MAP3K14 | 2.14738290 |
| 12 | MAP2K3 | 2.12562841 |
| 13 | CDK12 | 2.06793189 |
| 14 | TNK2 | 1.95665580 |
| 15 | SIK1 | 1.94201006 |
| 16 | BLK | 1.79714173 |
| 17 | TYK2 | 1.79695947 |
| 18 | IKBKE | 1.76086349 |
| 19 | NME2 | 1.67779355 |
| 20 | SMG1 | 1.66794820 |
| 21 | ZAP70 | 1.62257432 |
| 22 | TAOK2 | 1.58660972 |
| 23 | TESK2 | 1.58404130 |
| 24 | JAK3 | 1.48960044 |
| 25 | MAP3K3 | 1.45196103 |
| 26 | MAP3K13 | 1.44961840 |
| 27 | IKBKB | 1.43927687 |
| 28 | FES | 1.43480508 |
| 29 | MATK | 1.41636620 |
| 30 | CSK | 1.40142566 |
| 31 | PKN2 | 1.39214708 |
| 32 | RIPK1 | 1.33872827 |
| 33 | GRK6 | 1.29741575 |
| 34 | MAP3K10 | 1.28487943 |
| 35 | CDC42BPA | 1.25321383 |
| 36 | TGFBR2 | 1.24914748 |
| 37 | IRAK2 | 1.23951962 |
| 38 | SIK3 | 1.23523043 |
| 39 | CDK4 | 1.21656620 |
| 40 | FGR | 1.19912996 |
| 41 | MAP3K1 | 1.17782273 |
| 42 | CSF1R | 1.16876968 |
| 43 | BTK | 1.11889558 |
| 44 | TESK1 | 1.09134347 |
| 45 | SYK | 1.02861288 |
| 46 | HCK | 0.94784312 |
| 47 | MARK2 | 0.93988872 |
| 48 | ICK | 0.93864012 |
| 49 | GRK7 | 0.92517596 |
| 50 | LYN | 0.90471744 |
| 51 | EPHB1 | 0.90151005 |
| 52 | MARK3 | 0.89637562 |
| 53 | CDK6 | 0.87151013 |
| 54 | RPS6KL1 | 0.86198613 |
| 55 | RPS6KC1 | 0.86198613 |
| 56 | IRAK1 | 0.85677303 |
| 57 | SIK2 | 0.85020258 |
| 58 | PRKD2 | 0.84769760 |
| 59 | LCK | 0.84102957 |
| 60 | BMPR2 | 0.83208336 |
| 61 | CHUK | 0.82789207 |
| 62 | RPS6KA2 | 0.79553156 |
| 63 | TTN | 0.79317126 |
| 64 | RPS6KA6 | 0.73265289 |
| 65 | EPHA2 | 0.70598255 |
| 66 | HIPK2 | 0.69834170 |
| 67 | PDK1 | 0.69001147 |
| 68 | PTK6 | 0.67659768 |
| 69 | TXK | 0.66123516 |
| 70 | KIT | 0.65181467 |
| 71 | JAK2 | 0.64633410 |
| 72 | MAPKAPK3 | 0.63803565 |
| 73 | MAP3K6 | 0.63580956 |
| 74 | MOS | 0.62785196 |
| 75 | PDPK1 | 0.62775969 |
| 76 | KDR | 0.58438091 |
| 77 | STK38 | 0.57799133 |
| 78 | JAK1 | 0.56962705 |
| 79 | MAPKAPK2 | 0.56902187 |
| 80 | MAP3K8 | 0.56389932 |
| 81 | MAP2K2 | 0.54518161 |
| 82 | RPS6KB2 | 0.52823083 |
| 83 | PIM2 | 0.52806594 |
| 84 | MAP2K6 | 0.52375664 |
| 85 | CDK9 | 0.51577044 |
| 86 | KSR2 | 0.49127173 |
| 87 | LIMK1 | 0.48642140 |
| 88 | PAK4 | 0.47569120 |
| 89 | STK10 | 0.47098393 |
| 90 | BRD4 | 0.44576482 |
| 91 | EEF2K | 0.44536172 |
| 92 | RET | 0.43152386 |
| 93 | ITK | 0.42469770 |
| 94 | MAPK12 | 0.42153986 |
| 95 | PIK3CG | 0.41586473 |
| 96 | CAMKK1 | 0.40878078 |
| 97 | MAPK11 | 0.39019408 |
| 98 | RPS6KA4 | 0.38905891 |
| 99 | DDR2 | 0.37884534 |
| 100 | RPS6KA1 | 0.36305395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.43125161 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71221615 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36788502 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27532613 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.15617297 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.11444207 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11197280 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.04296098 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96595111 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93823998 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.92871119 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89716840 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84413796 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.83668153 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82427771 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67775376 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.62578038 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60551796 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55405213 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54122027 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51160287 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50624572 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48956467 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47606428 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.47519349 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46635360 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46562372 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.46555409 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44128323 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39151406 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37835700 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.35277669 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.33094931 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26663593 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.24437126 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.21253413 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19717120 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.19256483 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17075217 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14091615 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13957551 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.13835311 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12193836 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.12007217 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11777392 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.10718277 |
| 47 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09066364 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06876826 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05822597 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05548005 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.05174640 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02825769 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02121895 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00010037 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98904011 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98883327 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.97730785 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97641992 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96889092 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92282602 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91799437 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.90449435 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88238540 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85700825 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.83538260 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81402994 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79633877 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79257105 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77882629 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70781496 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70499742 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.68818540 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68424677 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66412122 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.64051887 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63412493 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60571247 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59428268 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59274862 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57676035 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56639112 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55064430 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.52331044 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52282572 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.51617185 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51094435 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.50265699 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49618205 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49530404 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49372108 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47929197 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46560422 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46528991 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45734859 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44418713 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43045581 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41474349 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39782951 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39682701 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39615151 |

